Unlike pharmaceutical drugs approved by regulatory bodies such as the EMA or FDA, Dihexa lacks formal clinical trial protocols specifying safe and effective doses for humans
Neurological: Numbness or tingling in the extremities (paresthesias), difficulty walking, balance problems, muscle weakness, vision problems, cognitive disorders (difficulty concentrating, memory loss), mood changes (depression, irritability)
high count of a certain white blood cell (eosinophilia)
Disclaimer Not Evaluated by the FDA These statements have not been evaluated by the FDA, and MIC+B12 injections are not approved to diagnose, treat, cure, or prevent any disease beyond recognized indications
Amylin regulates gastric emptying, suppresses glucagon secretion, and promotes satiety via central nervous system pathways
Experience the innovation of the B12 Patch Dr